Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) does not directly cause haemorrhoids, but constipation is a recognised side effect and straining during constipation is one of the most common triggers for piles developing or worsening. Understanding that connection is the practical first step. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber reviews whether it is clinically appropriate for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide slows gastric emptying, food travels through your digestive system more slowly, which is part of why appetite falls and blood-sugar spikes flatten. That's useful clinically, but for the bowel it can mean stools become harder and less frequent. The NHS patient information on tirzepatide lists constipation alongside nausea and diarrhoea as common side effects, meaning it affects at least one in ten people at some point during treatment.
This slowdown is usually most pronounced early on, particularly when starting at 2.5 mg or moving to a higher dose. For most people it is temporary. The bowel adjusts over days to a few weeks. Understanding this timing matters because it tells you when the risk of piles-related straining is highest, and when extra care is most worthwhile.
Haemorrhoids form when the blood vessels around the lower rectum and anus come under repeated pressure. Straining to pass a hard stool is the classic cause, and anything that makes constipation more likely raises that risk indirectly. Mounjaro itself does not appear in the clinical literature as a direct cause of haemorrhoids, and they are not listed in the Mounjaro SmPC on the eMC as a named adverse reaction. But the pathway from slowed gut motility to constipation to straining to piles is clinically logical and well-recognised.
People who already had haemorrhoids before starting Mounjaro may notice they flare during a constipation episode. People who have never had them are not immune if constipation becomes persistent and unmanaged. If you want a fuller picture of the gut-related effects worth knowing about, the Mounjaro and IBS page covers bowel symptoms more broadly.
A few evidence-backed habits make a real difference. Fluid intake is the most important lever, aim for at least six to eight glasses of water daily; the pill you take before the kettle goes on in the morning counts as one. Dietary fibre from vegetables, wholegrains and pulses softens stool and supports regular movement. Gentle activity, even a daily walk, helps gut motility. Over-the-counter stool softeners or bulk-forming laxatives are widely used alongside GLP-1 medicines; speak to a pharmacist or your prescriber before adding them, especially if you have other health conditions.
If you already have piles, a topical preparation from a pharmacist can ease discomfort while symptoms settle. Avoid straining, take your time and do not sit on the toilet for extended periods. If symptoms persist beyond a week or two, or if you notice rectal bleeding, a GP review is the right step. Bleeding should never be assumed to be haemorrhoids without clinical assessment.
For context on the broader range of side effects people ask about, the overview of what Mounjaro can cause covers the full picture from the trial data. Pricing and treatment options are outlined on the Mounjaro cost page for anyone weighing up private treatment.
A few symptoms should prompt you to contact a GP or go to urgent care rather than wait. Rectal bleeding that is bright red and more than a small amount, or bleeding mixed into the stool rather than on the tissue, needs clinical assessment. Severe or worsening pain around the rectum, a lump that cannot be gently pushed back, or any sign of infection (swelling, heat, fever) all warrant prompt attention. These are not signs to manage at home while waiting for symptoms to pass.
The MHRA Yellow Card scheme allows patients and carers to report suspected side effects from any medicine, including Mounjaro, reporting unusual or unexpected symptoms contributes to the ongoing safety monitoring all Black Triangle medicines receive. Our clinical team is available seven days a week if you have concerns between consultations. For a deeper look at the specific evidence around haemorrhoids and tirzepatide, the dedicated piles and Mounjaro page goes further into the literature, and anyone curious about how tirzepatide was developed and approved will find that background useful for understanding where the drug sits within the wider treatment landscape.
If you are considering starting Mounjaro and want to understand whether it is clinically suitable for you, check your eligibility through a free consultation with one of our GPhC-registered prescribers. Patients sometimes ask about neurological concerns too, and our page on whether Mounjaro can cause MS addresses that question directly using the available evidence.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.